Targeting MEX3A attenuates metastasis of breast cancer via β-catenin signaling pathway inhibition.
Wang Y, Liang Q, Lei K, Zhu Q, Zeng D, Liu Y, Lu Y, Kang T, Tang N, Huang L, Ye L, Tang D, Zhu C.
Wang Y, et al. Among authors: lei k.
Cancer Lett. 2021 Aug 21;521:50-63. doi: 10.1016/j.canlet.2021.08.022. Online ahead of print.
Cancer Lett. 2021.
PMID: 34425185